Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

C1orf228 Inhibitors

The class of "C1orf228 Inhibitors" encompasses a diverse range of chemical compounds, each with unique biochemical properties and specific mechanisms of action. While these compounds are not directly linked to C1orf228, they are known to modulate various cellular signaling pathways and processes that could indirectly influence the activity of proteins encoded by the C1orf228 gene or functionally similar proteins.

mTOR inhibitors like Rapamycin play a crucial role in regulating cell growth and autophagy, processes that could be relevant to the function of C1orf228. Similarly, PI3K inhibitors such as Wortmannin and LY294002 affect critical pathways in cell survival and proliferation, potentially impacting proteins involved in similar processes to those regulated by C1orf228.

Histone deacetylase inhibitors like Trichostatin A alter gene expression patterns and chromatin structure, potentially affecting proteins at a transcriptional level, including those related to C1orf228. Proteasome inhibitors such as Bortezomib impact protein degradation pathways, a critical aspect of cellular regulation, which might include proteins functionally related to C1orf228.

MEK inhibitors like PD98059 and p38 MAPK inhibitors such as SB203580 target key components of cell signaling pathways, such as the MAPK/ERK and stress response pathways, respectively. Their broad-spectrum activity can have a significant impact on various pathways, potentially affecting proteins involved in cell proliferation, differentiation, and stress responses related to C1orf228.

Multi-kinase inhibitors like Sorafenib and Sunitinib, and the broad-spectrum tyrosine kinase inhibitor Dasatinib, exhibit diverse effects on cell proliferation, angiogenesis, and apoptosis, potentially influencing the regulation of proteins functionally related to C1orf228. Natural compounds like Curcumin, with their wide range

of biological activities, might modulate various enzyme activities and signaling pathways, potentially affecting proteins functionally related to C1orf228. SP600125, a JNK inhibitor, affects pathways related to apoptosis and cellular stress responses, which could have indirect implications for the modulation of C1orf228 activity.

In summary, the "C1orf228 Inhibitors" class, though theoretical, represents a comprehensive approach to understanding and potentially modulating cellular signaling pathways and processes. These compounds serve as valuable tools for research into the functional aspects of proteins and their roles in various cellular processes. While direct inhibitors of C1orf228 are not specified due to the lack of detailed information on the protein, this class of inhibitors presents a broad method for exploring the modulation of protein activity within complex cellular networks.

The exploration of these inhibitors enhances our understanding of the potential role of C1orf228 in cellular processes and offers insights into how various signaling pathways and regulatory mechanisms can be modulated to influence protein activity. This approach is crucial for unraveling the complexities of cellular signaling pathways and provides valuable tools for research into the functional aspects of proteins like C1orf228. The insights gained from studying these inhibitors can lead to a better understanding of cellular dynamics and offer potential avenues for the development of targeted strategies to modulate protein activity, particularly in the context of diseases or conditions where C1orf228 or similar proteins play a critical role.

Each compound, with its specific mode of action, provides a unique perspective on the potential regulation and modulation of cellular processes. From targeting key signaling molecules to affecting broader metabolic pathways, these inhibitors highlight the intricate interplay within cellular signaling networks. Such understanding is vital for advancing our knowledge of cellular biology. The diverse range of these compounds, encompassing kinase inhibitors, natural compounds, and other modulators, underscores the complexity of cellular regulation and the importance of a multifaceted approach in studying protein functions and interactions.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor, potentially affecting cell growth and autophagy pathways relevant to C1orf228.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor, potentially impacting AKT signaling pathways relevant to C1orf228.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor, potentially affecting gene expression related to C1orf228.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, potentially influencing the MAPK/ERK signaling pathway relevant to C1orf228.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, possibly influencing protein degradation pathways linked to C1orf228.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, potentially impacting stress response pathways linked to C1orf228.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, possibly affecting pathways relevant to C1orf228.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multi-kinase inhibitor, potentially impacting signaling pathways associated with C1orf228.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Compound from turmeric, potentially modulating various enzyme activities and signaling pathways related to C1orf228.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Multi-kinase inhibitor, potentially influencing angiogenesis and cell proliferation pathways relevant to C1orf228.